Background. Although the technical success rate of coronary angioplasty in the elderly is high, very old patients have increased risk of procedure-related death and late recurrence of severe angina. We proposed to determine baseline variables that predict early and intermediate-term failure of percutaneous transluminal coronary angioplasty (PTCA) in patients more than 65 so we could effectively stratify risk.
P revious reports have emphasized the increased mortality and late recurrence of angina after percutaneous transluminal coronary angioplasty (PTCA) in patients more than 65 years old, particularly among those of advanced age.1-15 The increase in morbidity and mortality in this age group is also seen in patients treated medically and in those undergoing coronary bypass surgery, although a survival benefit from bypass surgery over medical therapy has been shown in subgroups of the elderly, as it has in younger patients.11,12 Percutaneous transluminal coronary angioplasty is an attractive therapeutic option in older patients, particularly in those with comorbid conditions that complicate the use of both medical therapy and bypass surgery. Nonetheless, the increased morbidity and mortality of elderly patients undergoing PTCA warrant careful evaluation of risk and benefit. For these reasons, our study was designed to examine those variables that might predict the early and late outcomes of PTCA in the elderly to identify the patients most likely to benefit from the procedure.
Methods

Patient Population
The patient population included 982 patients at least 65 years old who had undergone elective or urgent PTCA at the Mayo Clinic between April 1980 and January 1, 1990 . This group included all elderly patients undergoing PTCA except those who underwent PTCA for treatment of acute myocardial infarction and patients whose only procedure was unsuccessful PTCA of a totally occluded vessel (n=41). At the time of PTCA, all patients were enrolled into a prospective data registry. PTCA was performed, and hospital and subsequent clinical information was collected by trained technicians, as previously described.14,5,16-lS Mean length of follow-up was 25 months (median, 20 months) and was obtained for all the patients.
Statistical Analysis
Predictors of in-hospital and late outcomes were assessed by univariate or multivariate logistic regression or Cox proportional hazards models, respectively. Initially, the 35 variables chosen were considered as po- tential predictive variables in these analyses (Tables 1  and 2 ). Stepwise analysis was performed, and the models developed on one half of the data were tested on the other half. The models that were selected tended to have poorer performance when tested on the second half of the data, and the data suggested overselection of variables. This led us to pare the list of variables, choosing nine that were less intercorrelated. The nine variables were age, the number of coronary artery segments stenosed by a lesion with at least 70% severity, recent congestive heart failure, presence of unstable angina, whether the PTCA lesion was eccentric, lesion thrombus, lesion calcium, presence of proximal left anterior descending artery stenosis of at least 70%, and an index score of other medical diseases. Angiographic left ventricular ejection fraction was not used in the analysis because this information was not available for every patient. For this reason, the statistical analysis was repeated separately, adding the parameter of left ventricular ejection fraction for those patients for whom the angiographic ejection fraction was available (see "Results").
Definitions
Significant coronary artery disease was defined as at least 70% intraluminal diameter coronary artery stenosis visually estimated with biplane orthogonal views. Angiographically defined lesion eccentricity, thrombus, and calcification were coded by the physician performing the PTCA in accordance with the criteria of the National Heart, Lung, and Blood Institute PTCA Registry.16 Successful coronary dilation and unstable angina were defined as previously published.1 For coronary artery segments, a previously described division of the coronary tree into 27 segments was used. 19 The index of other medical diseases was the number of certain other comorbid medical conditions listed by the patient's attending physician. The possible conditions included chronic obstructive pulmonary disease, cerebrovascular disease, malignancy other than skin cancer, peripheral vascular disease, renal failure, hypertension, and diabetes.
Development of the Predictive Model
Four end points indicative of adverse outcome were used: two in-hospital and two after dismissal. In-hospital outcome end points included end point 1, death or myocardial infarction, and end point 2, death, myocardial infarction, unsuccessful PTCA, repeat PTCA, or urgent coronary artery bypass graft (CABG). Late (after hospitalization) outcome end points in hospital survivors with a successful PTCA included end point 3, death or myocardial infarction, and end point 4, death, myocardial infarction, need for bypass surgery, repeat PTCA, recurrent class III or class IV angina, or hospital admission for angina. After selecting the subset of nine candidate predictor variables, forward stepwise logistic regression procedures for the two in-hospital outcomes and forward stepwise Cox proportional hazards model procedures for the two late outcomes were performed. The resulting models were used to generate estimated risk scores and probabilities of adverse events. Patients were divided into quintiles of risk on the basis of these scores. The predicted risk for the logistic model was the standard logistic risk equation. For the proportional hazards model, each patient's predicted survival curve was obtained from the model estimates of hazard ratios and underlying survival function ( Table 3 ).
The predicted risks or survival curves within risk quintiles were averaged to create a predicted survival probability or survival curve within each quintile of risk. These were compared with the within-quintile observed proportion surviving in the case of the in-hospital outcomes or with the observed Kaplan-Meier survival curves in the case of the late outcomes.
Cross Validation of the Predictive Model
The method of cross validation was used to test model performance when applied to new patients. Patients model-fitting procedure (including the stepwise selection) was applied successively to the 10 subsets of patients formed by deleting each of these groups from the total group. Thus, approximately 90% of the patients were used in each of the 10 model-fitting procedures. The models so obtained were used to estimate and to classify risk for the remaining 10% of patients. Thus, every patient's risk was estimated and classified by a model that did not use that patient in the process of model construction or estimation. This produced a relatively unbiased assessment of model performance in new patients.20,21 The model actually reported was the one based on all the patients, but its performance was evaluated with the cross-validation method.
Separate Analysis of Completeness of Revascularization
The predictive model we developed used baseline parameters that were known to the clinician before the angioplasty procedure. Thus, information about the outcome of PTCA was not used in the predictive formula. To assess the impact of the completeness of revascularization on the predictions of outcome, a separate analysis was performed. The modeling procedure was repeated with the nine baseline parameters plus the nonbaseline parameter of the number of segments with at least 70% stenosis after PTCA. Thus, the additional predictive value of residual coronary artery lesions was tested for each of the end points in our model.
Results
The mean age of our patients was 71.9 years (range, 65 to 94 years) ( Table 4 ); 61.6% were men, and the prevalences of class III or IV angina (65.9%), rest angina (18.6%), and a history of myocardial infarction (46.9%) were high. Multivessel disease was present in 51.5%. One-vessel dilatation was most commonly performed (66%); 26.7% had dilatation of two vessels, and 7% had dilatation of at least three vessels. The success rate was 89.5%. Table 1 lists the baseline variables used for the stepwise logistic model and their overall distribution. The majority of patients had unstable angina, and nearly 70% of them had significant stenosis of the left anterior descending artery.
The partial x2 and P values for the nine variables selected in each of the final models are given in Table 5 . The number of coronary artery segments stenosed at least 70% was a significant, independent predictor for each of the composite end points.
Outcome Table 6 lists the incidence of various early and late patient outcomes. There was a 6.3% incidence of procedure-related myocardial infarction or death. The incidence of total adverse in-hospital outcomes (infarction, death, bypass surgery, repeat angioplasty, recurrent angina) was 18.7%.
Composite Outcomes and Risk Stratification
Procedure-related acute myocardial infarction or death. The number of 70% coronary stenoses and age were the only two baseline parameters that were predictors of in-hospital myocardial infarction or death in the logistic regression model. The Expected and actual event rates of in-hospital death or myocardial infarction. Lowest risk quintile had a substantially lower event rate than the highest risk quintile. Expected event rates are very close to the actual event rates and fall within their 95% confidence intervals. The probability of these adverse events in the lowest risk quintile was 2.9%, compared with 14% in the highest quintile. In other words, the "average" patient in this group, a 68-year-old with one coronary artery segment with 70% stenosis before PTCA, has a 2.9% chance of procedure-related death or myocardial infarction, but the chance for the "average" high-risk patient, a 78-year-old with four stenosed coronary artery segments, is 14% (Fig 1) .
Cumulative adverse in-hospital events: unsuccessful PTCA, death, myocardial infarction, urgent or emergency bypass surgery, repeat in-hospital PTCA, or severe angina after PTCA in the hospital. The only baseline parameter that was significantly associated with poor outcome was the number of coronary artery segments with at least 70% stenosis. Age was weakly associated (X 2=3.34) and was not included in the regression equation. The logistic risk score for in-hospital adverse events was logit (P)= -1.92+0.20x number of 70% lesions.
The patients in the lowest quintile of risk had a 17.2% incidence of in-hospital adverse events, and those in the highest quintile had a 29% incidence. In other words, an elderly patient with one coronary artery segment with at least 70% stenosis had a 17.2% chance of adverse in-hospital events, and a patient with four or five such coronary artery segments had a 29% chance (Fig 2) . Years Late Outcome Posthospital mortality or myocardial infarction. The number of 70% stenotic lesions was again one of the baseline variables that was a significant independent predictor of after-hospitalization mortality or myocardial infarction and was used in the regression equation. Also included, however, were the presence of recent congestive heart failure and the number of concomitant medical diseases.
At 3 years' follow-up, the overall event rate was 15%. The lowest risk quintile had an event rate of 4% and the highest risk quintile had an event rate of 33% (Fig 3) . A typical, or "average," patient in the lowest risk quintile had a single significant coronary artery stenosis, no recent congestive heart failure, and no other important medical diseases. In contrast, the "average" patient in the highest risk quintile had three significant stenoses of coronary artery segments, recent congestive heart failure, and two other concomitant medical diseases.
The data were analyzed separately, adding the parameter of ejection fraction in those patients in whom an angiographic ejection fraction was available; this baseline parameter replaced the variable of recent congestive heart failure in the predictive model of this end point (see below).
Cumulative adverse events during follow-up. For the fourth end point of total late adverse events, the baseline variables that were predictive and that were used in __ _I--. Years the regression equation included the number of coronary artery segments with 70% stenotic lesions, the presence of unstable angina, and the number of concomitant medical diseases. The overall event rate at 3 years was 47%. Patients in the lowest risk quintile (eg, typical patient with one significantly diseased coronary artery segment, stable angina, and one or no other medical disease) had a 28% event rate at 3 years, whereas patients in the highest risk quintile (eg, "average" patient with three or four significantly diseased coronary artery segments, unstable angina, and two or three concomitant diseases) had a 63% event rate at 3 years (Fig 4) .
Cross-Validation Results
With cross validation, we found that the actual event rate was relatively close to the number of events predicted by our method . Figs 1 and 2 show the actual versus the predicted number of events for in-hospital outcomes, and Figs 5 and 6 show the comparison of predicted events versus actual events over time for the highest and lowest risk groups after hospital dismissal.
Separate Analysis Using Ejection Fraction
The results were reanalyzed, and a new model was generated for each of the four end points in the portion of the population for which the ejection fraction was available (817 patients) by adding the parameter of ejection fraction as a 10th baseline variable. Analyzed in this manner, ejection fraction was an independent predictor of outcome for the end point of cumulative survival free of myocardial infarction (end point 3). Ejection fraction was not an independent predictor of outcome for in-hospital events or for the end point of cumulative late event-free survival (end point 4).
Also in this analysis, the baseline parameters that became predictive of cumulative myocardial infarctionfree survival were the number of concomitant diseases, ejection fraction, and the number of coronary artery segments with at least 70% stenosis. Thus, ejection fraction replaced the variable of recent congestive heart failure in the predictive model for this portion of the population.
The partial x2 value for ejection fraction for each of the four outcomes is listed in Table 7 .
Completeness of Revascularization
When added to the analysis, the nonbaseline parameter of the number of coronary artery segments with at least 70% stenosis after PTCA was not a stronger predictor than the number of stenoses before PTCA. The number of segment stenoses after PTCA did not provide additional predictive value and did not enter or change the original predictive formula for any of the Years four end points. For outcome of cumulative late eventfree survival (end point 4), this parameter approached but did not achieve significance (P=.09; X2=2.9) after allowing for the baseline parameters. The mean number of segment stenoses after PTCA was 1.1.
Distribution of Key Baseline Parameters and Outcomes
The distribution of the number of diseased coronary segments, the age range of the study population, and the number of hospital deaths/myocardial infarctions per year of the study period are illustrated in Figs 8, 9, and 10, respectively.
Discussion
The expanding population of elderly patients with symptomatic cardiovascular disease is reflected by the steadily increasing number of invasive cardiovascular procedures performed in the United States. At our institution, individuals more than 65 years old now make up the majority of patients referred for PTCA and CABG.1,6 The benefits of surgery over medical therapy on symptoms and survival are maintained in the elderly as they are in the younger population,11 '12,15 but the perioperative morbidity is significantly increased. [11] [12] [13] 15, [22] [23] [24] [25] Nonetheless, as a group, elderly patients with severe symptomatic coronary artery disease are particularly difficult to manage with medical therapy alone.26-28 The attraction of PTCA over CABG in elderly patients is obvious but only if it can be shown that there is a reasonable chance of achieving a prolonged period of benefit and that the risk of the acute procedure is reasonably low. With this in mind, we developed several statistical models that allowed us to categorize potential recipients of PTCA into subgroups at high, low, and intermediate risk of Predicted and observed event rates were very close. 4 both early and late adverse outcomes. The heterogeneity of the elderly is emphasized by the markedly disparate range of outcomes in groups stratified on the basis of the predictive model. In our study, the most powerful baseline predictor of an adverse outcome after PTCA was the extent of coronary artery disease as defined by the number of coronary artery segments with significant obstructive disease. The number of segments with a stenosis of at least 70% was the most heavily weighted parameter in the probability regression equation for in-hospital death or myocardial infarction, total adverse hospital outcome, and cumulative late adverse events. Age per se, although significant, was relatively less important.
Other investigators have found that three-vessel coronary artery disease is an important predictor of poor late outcome after PTCA in the elderly.29'30 The method we used of dividing the coronary arterial tree into 27 segments gives a more precise measure of the extent of coronary artery disease than does the number of diseased vessels. With this approach, our results emphasize the powerful adverse impact of diffuse coronary artery disease on the early and late results of PTCA.
It has been shown in several surgical series that the presence of concomitant medical conditions has a pow- 
Issue of Complete Revascularization
Cardiac surgical data support the importance of complete revascularization for long-term outcome, and this appears to be the most desirable goal of therapy. The diffuseness of disease in the elderly and the high rate of recurrent angina in our initial series appear to make a strong case for more extensive revascularization at the time of the initial PTCA. However, this must be balanced by the frequency of restenosis using such an approach. PTCA is less likely than CABG to achieve complete revascularization, but in some patients, especially those with preserved left ventricular function, incomplete revascularization may still be effective. [29] [30] [31] [32] [33] [34] [35] What is not established is the proportion of elderly patients in whom PTCA alone will provide adequate revascularization. A reasonable approach is to favor a policy of dilating every lesion considered to be the cause of significant ischemia as opposed to proceeding with PTCA on the basis of anatomic lesions alone. 
Cross Validation
The use of cross validation is an important feature of any predictive analysis. When model fitting is done retrospectively either with many candidate variables or with data-driven methods such as stepwise selection, there is great potential for "overfitting," ie, generating a model that is tailored to the specific data set but not generalizable. Cross validation can be performed many ways, but our choice was designed to use as much of the data (90%) as possible, thus reflecting the behavior of our model using the entire data and having the feature that each observed outcome was compared with a prediction based on a model determined independent of that observation. The fact that our predictions and observations matched well suggested that we did not have a significant problem with overfitting and that our models should be relatively generalizable.
Summary
Our data stratify patients at high and low risk for adverse events after PTCA. These results may help with treatment decisions. Many elderly patients with coronary artery disease do not accept the severe limitation of angina pectoris. For them, PTCA appears to be an attractive option, and our results identify subgroups of patients in whom this approach appears to be particularly appropriate.
